Imatinib Impurity 9 CAS CATO-C4X-10689
| CAS No. | CATO-C4X-10689 |
| Molecular Formula | C53H51N12O2 |
| Molecular Weight | 888.05 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Imatinib Impurity 9.
CATO supplies Imatinib Impurity 9 (CAS CATO-C4X-10689), a pharmacopoeial impurity reference standard (molecular formula C53H51N12O2, MW 888.05 g/mol) used for the identification and quantification of trace impurities in APIs.
Structurally, Imatinib Impurity 9 (C53H51N12O2) contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage. The molecule exhibits a degree of unsaturation (DBE) of 34.5, corresponding to approximately 34 ring(s) or double-bond equivalent(s). With a molecular weight of 888.05 g/mol, it falls into the high-molecular-weight range. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Imatinib Impurity 9 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C53H51N12O2 |
| Molecular Weight | 888.05 g/mol |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 34.5 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Nitrogen Atoms | 12 |
Related Imatinib Standards
- Imatinib EP Impurity D (CAS 1821122-73-9)
- Imatinib Impurity 43 (CAS CATO-C4X-106843)
- Imatinib bis Impurity (CAS 1365802-18-1)
- Imatinib Impurity 22 (CAS 1356565-46-2)
- Imatinib Impurity 40 (CAS CATO-C4X-106840)
- Imatinib Impurity 11 (CAS CATO-C4X-106811)
- Imatinib Impurity 41 (CAS CATO-C4X-106841)
- Imatinib Impurity 92 (CAS CATO-C4X-106892)
Recommended Standards
- Semaglutide Impurity 147 (CAS CATO-C4X-2226147)
- 2'-OMe-A(Bz)Phosphoramidite (CAS 110782-31-5)
- Ursodeoxycholic Acid impurity 99 (CAS CATO-C4X-142299)
- DMT-dA(PAc) Phosphoramidite (CAS 110543-74-3)
- Irinotecan Impurity 27 (CAS 802277-44-7)
- Faropenem Impurity 20 (CAS CATO-C4X-128920)
- Beclometasone Impurity 51 (CAS CATO-C4X-147451)
- 2-(4-Chloro-2-methylphenoxy)-2,2-difluoro-1-morpholinoethan-1-one (CAS 400088-75-7)
- 1-Fluoro-3-(1,1,1,3,3,3-hexafluoropropan-2-yloxy)-2-(trifluoromethyl)benzene (CAS 1774895-18-9)
- 1-(tert-Butyl) 4-ethyl 2-methyl-5-oxopiperidine-1,4-dicarboxylate (CAS 2766053-10-3)
- (5-Bromo-2-propan-2-yloxypyridin-3-yl)methanol (CAS 1247740-36-8)
- 2-((1S,2S)-2-Aminocyclohexyl)acetic acid hydrochloride (CAS 1909287-12-2)
- Methyl 4-bromo-1-(difluoromethyl)-1H-pyrazole-3-carboxylate (CAS 1856095-64-1)
- Insulin Detemir (CAS 169148-63-4)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com